Oncolytics Biotech (ONCY) Return on Sales (2009 - 2020)
Oncolytics Biotech (ONCY) posted quarterly Return on Sales of 0.0% for Q3 2020, little changed year-over-year from 0.0% in Q4 2019, and down 12.65% quarter-over-quarter from 0.0% in Q2 2020.
Oncolytics Biotech (ONCY) Return on Sales (2009 - 2020) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Return on Sales for 7 consecutive years, with 0.0% the latest figure, recorded in Q3 2020.
- In Q3 2020, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Sep 2020 stood at 0.0% (changed 0.0% YoY), while the FY2018 annual figure was 0.0%, changed N/A from the prior year.
- Return on Sales declined to 0.0% in Q3 2020 per ONCY's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 1.87% in Q3 2018 and bottomed at 0.0% in Q2 2019.
- Historically, Return on Sales has averaged 0.19% across 5 years, with a median of 0.0% in 2019.
- Annual changes were most pronounced in 2019 — Return on Sales sank 187 bps — and 2020, when it changed 0 bps.
- Oncolytics Biotech's Return on Sales stood at 0.04% in 2016, then tumbled by 100 bps to 0.0% in 2017, then slumped by 96 bps to 0.0% in 2018, then slumped by 68209708 bps to 0.0% in 2019, then advanced by 24 bps to 0.0% in 2020.
- Business Quant data shows ONCY's Return on Sales at 0.0% in Q3 2020, 0.0% in Q2 2020, and 0.0% in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.00% |
| 10 | Oncolytics Biotech | 99.00 Mn | 99.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 1.87% |
| Jun 30, 2017 | 0.00% |
| Jun 30, 2016 | 0.04% |
| Jun 30, 2010 | 0.14% |
| Dec 31, 2009 | 0.00% |
| Sep 30, 2009 | 0.00% |
| Jun 30, 2009 | 0.00% |
| Mar 31, 2009 | 0.00% |